Glenmark Pharmaceuticals Limited

Global pharmaceutical company with 18 facilities, providing branded and generic formulations in various therapeutic areas.

1977 | Mumbai, Maharashtra (India) | Active
Last Updated:

Glenmark Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 277.00 Cr
  • Paid Up Capital ₹ 28.22 Cr
  • Company Age 47 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 890.00 Cr
  • Satisfied Charges ₹ 1,040.00 Cr
  • Revenue Growth -1.60%
  • Profit Growth 327.48%
  • Ebitda -15.69%
  • Net Worth 28.49%
  • Total Assets 11.50%

About Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Limited (GPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 18 November 1977 and has a history of 47 years and four months. Its registered office is in Mumbai, Maharashtra, India.

It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532296 and on the National Stock Exchange(NSE) under GLENMARK.

The Corporate was formerly known as Glenmark Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 277.00 Cr and a paid-up capital of Rs 28.22 Cr.

The company currently has active open charges totaling ₹890.00 Cr. The company has closed loans amounting to ₹1,040.00 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Glenmark Pharmaceuticals Limited India are V Mani as CFO and Harish Kuber as Company Secretary. Blanche Elizabeth, Rajesh Desai, Glenn Saldanha, and Five other members serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    L24299MH1977PLC019982

  • Company No.

    019982

  • Stock Symbol

    BSE : 532296 NSE : GLENMARK

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    18 Nov 1977

  • Date of AGM

    27 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Listed

  • ROC Code

    Roc Mumbai

Industry

Pharma

What products or services does Glenmark Pharmaceuticals Limited offer?

Glenmark Pharmaceuticals Limited offers a wide range of products and services, including Baby Care, Baby Skin Care, Ayurveda Products, Natural Hair & Skin Care, Hair Care, Hair Conditioners, Skin Care, Acne Care, Vitamins & Supplements, Multivitamins.

Company report

Glenmark Pharmaceuticals Limited

Explore comprehensive data for Glenmark Pharmaceuticals Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Glenmark Pharmaceuticals?

Executive Team (3)

NameDesignationAppointment DateStatus
Glenn Saldanha Country flag representing In Managing Director12-Oct-1998Current
V Mani Country flag representing In CFO28-Sep-2018Current
Harish Kuber Country flag representing In Company Secretary02-Feb-2017Current

Board Members (7)

NameDesignationAppointment DateStatus
Vijayalakshmi Iyer Country flag representing In Director 10-Feb-2023Current
Dipankar Bhattacharjee Country flag representing Gb Director 14-Aug-2020Current
Blanche Elizabeth Country flag representing In Director 14-Aug-2009Current
Rajesh Desai Country flag representing In Director 31-Mar-2017Current
Cherylann Pinto Country flag representing In Whole-Time Director 16-May-2007Current
V Mani Country flag representing In Whole-Time Director and Cfo 29-May-2018Current

Financial Performance of Glenmark Pharmaceuticals.

Glenmark Pharmaceuticals Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 1.6% decrease. The company also saw a substantial improvement in profitability, with a 327.48% increase in profit. The company's net worth Soared by an impressive increase of 28.49%.

Glenmark Pharmaceuticals revenue growth over time
Glenmark Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-1.60%
Revenue from Operations
-4.01%
Total Assets
11.50%
Profit or Loss
327.48%
Net Worth
28.49%
EBITDA
-15.69%

What is the Ownership and Shareholding Structure of Glenmark Pharmaceuticals?

In 2024, Glenmark Pharmaceuticals had a promoter holding of 46.65% and a public holding of 53.36%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹890.00 Cr

Satisfied Charges

₹1,040.00 Cr

Charges Breakdown by Lending Institutions

  • Bank Of India : 890.00 Cr

Latest Charge Details

DateLenderAmountStatus
21 May 1985Bank Of India₹890.00 CrOpen
29 Jul 2009Bank Of India₹60.00 CrSatisfied
18 Jun 2009Axis Bank Limited₹75.00 CrSatisfied
16 Jan 2009Central Bank Of India₹150.00 CrSatisfied
09 Jun 2008Bank Of India₹170.00 CrSatisfied

How Many Employees Work at Glenmark Pharmaceuticals?

Glenmark Pharmaceuticals has a workforce of 13458 employees as of Mar 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Glenmark Pharmaceuticals Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Glenmark Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glenmark Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Glenmark Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Glenmark Pharmaceuticals Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Glenmark Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

  • Director Appointment

    Vijayalakshmi Rajaram Iyer was appointed as a Director was appointed as a Director on 10 Feb 2023 & has been associated with this company since 2 years 2 months .

  • Charges

    A charge registered on 23 Sep 2004 via Charge ID 80033325 with State Bank Of India was fully satisfied on 22 Jun 2022.

  • Charges

    A charge registered on 09 Jun 2008 via Charge ID 10114486 with Bank Of India was fully satisfied on 05 May 2022.

  • Director Appointment

    Dipankar Bhattacharjee was appointed as a Director was appointed as a Director on 14 Aug 2020 & has been associated with this company since 4 years 7 months .

Recent News, Updates & Announcement

Frequently asked questions

  • What is the Incorporation or founding date of Glenmark Pharmaceuticals Limited?

    Glenmark Pharmaceuticals Limited was incorporated on 18 Nov 1977.

  • What is authorized share capital and paid-up capital of Glenmark Pharmaceuticals Limited?

    The authorized share capital of Glenmark Pharmaceuticals Limited is ₹ 277.00 Cr and paid-up capital is ₹ 28.22 Cr.

  • Who are the current board members & directors of Glenmark Pharmaceuticals Limited?

    Currently 10 directors are associated with Glenmark Pharmaceuticals Limited.

    • Blanche Saldanha Elizabeth
    • Rajesh Vasudeo Desai
    • Glenn Mario Saldanha
    • Cherylann Maria Pinto
    • V S Mani
    • Vijayalakshmi Rajaram Iyer
    • Sona Saira Ramasastry
    • Dipankar Bhattacharjee
    • V S Mani
    • Harish Vinayak Kuber

  • What is the registered address of Glenmark Pharmaceuticals Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Glenmark Pharmaceuticals Limited is B-2Mahalaxmi Chambers22 Bhulabhai Desai Road Mahalaxmi India, Mumbai, Maharashtra, 400026.

  • What is the corporate identification number (CIN) and company number of Glenmark Pharmaceuticals Limited?

    The corporate identification number (CIN) of Glenmark Pharmaceuticals Limited is L24299MH1977PLC019982 and the company number is 019982 as per Ministry of Corporate Affairs (MCA).

  • Is Glenmark Pharmaceuticals Limited registered with any stock exchange in India?

    Yes, Glenmark Pharmaceuticals Limited is registered on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE): GLENMARK.

  • What is the official website of Glenmark Pharmaceuticals Limited?

    The Official website of Glenmark Pharmaceuticals Limited is https://www.glenmarkpharma.com

  • What has been the recent revenue trend for Glenmark Pharmaceuticals Limited?

    According to the financial reports for the fiscal year 2024, the revenue trend for Glenmark Pharmaceuticals Limited has fallen by -1.60%.

  • How many employees does Glenmark Pharmaceuticals Limited currently have?

    As Per 2024 financial reports, 13458 employees are currently employed by Glenmark Pharmaceuticals Limited.

  • What change has been observed in the net worth of Glenmark Pharmaceuticals Limited, and by what percentage?

    The financial reports for the fiscal year 2024 indicates that The net worth of Glenmark Pharmaceuticals Limited has experienced an upsurge of 28.49%.

  • What are the total open charges for Glenmark Pharmaceuticals Limited?

    As per the financial statements for fiscal Year 2024, The total open charges for Glenmark Pharmaceuticals Limited amount to ₹ 890.00 Cr.

  • When was the last Balance Sheet of Glenmark Pharmaceuticals Limited filed with the ROC?

    The most recent Balance Sheet for Glenmark Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on API Manufacturers